The Pharmaceutical Outcomes & Policy Innovations program was established in 1991 under the directorship of Dr. Bruce Carleton. The goal of the program — to improve the safety and cost effectiveness of medication use in children — has remained unchanged over POPi's nearly 30-year history.
The early focus of the program was community management of asthma and the investigation of changes in healthcare service utilization resulting from BC Ministry of Health policy. More recently, pharmacogenomics and pharmacoepidemiology are the most prominent areas of research.
POPi's research projects have increased in complexity and the trainees and staff increased in number with continuing success in obtaining research funding from national and provincial grant agencies. Nevertheless the overarching goal remains to improve patient care through better drug use.